Ashwagandha For Thyroid Function Research

Table of Contents

1. What Is Ashwagandha and Why Are People Using It for Thyroid Health?
2. The Key Clinical Trial: 8-Week Randomized Study on Subclinical Hypothyroidism
3. What Happened to T3, T4, and TSH in the Study?
4. Animal Research and Preclinical Evidence
5. Safety Concerns: Thyrotoxicosis Case Reports
6. Ashwagandha and Hashimoto's Thyroiditis
7. Ashwagandha and Hyperthyroidism: A Crucial Warning
8. Dosage and Duration: What the Research Used
9. Can Ashwagandha Interfere With Thyroid Medication or Lab Testing?
10. What the Research Does Not Yet Tell Us
11. Frequently Asked Questions
12. The Bottom Line

Support Your Stress Response, Lower Cortisol and Feel Calmer, Clearer and More Like Yourself Again.

Try our new organic cortisol balance drops risk free

Verdant Cortisol Balance Drops - Calm Stress & Sleep Deeper

Shop Organic Cortisol Balance Drops

What Is Ashwagandha and Why Are People Using It for Thyroid Health?

Ashwagandha — known botanically as Withania somnifera — is a small woody shrub native to India, North Africa, and parts of the Mediterranean. For more than 3,000 years, Ayurvedic practitioners have classified it as a rasayana, meaning a rejuvenating tonic believed to promote physical and mental vitality. Today it sits firmly in the mainstream supplement market, with millions of people reaching for it hoping to reduce stress, improve sleep, and support hormonal balance.

One of the more compelling areas of emerging interest is the relationship between withania somnifera thyroid function, and whether this ancient adaptogen can genuinely move the needle on thyroid hormone levels. That question matters enormously. The thyroid gland regulates metabolism, body temperature, heart rate, mood, and energy. When it underperforms — a condition known as hypothyroidism — the consequences ripple through virtually every system in the body.

Subclinical hypothyroidism is a particularly tricky territory. Defined as elevated thyroid-stimulating hormone (TSH) with still-normal free T3 and T4 levels, it affects an estimated 3–15% of the general population depending on the cut-off used. Many physicians opt to monitor rather than medicate at this stage, leaving patients in a gray zone where symptoms may be present but pharmaceutical intervention has not yet started. It is precisely this population — people with ashwagandha subclinical hypothyroid overlap — that the most relevant human clinical trial has examined.

Before diving into the data, a word on research quality: most health claims about adaptogens lean heavily on traditional use and animal models. What makes the ashwagandha thyroid research stand out from most herbal supplement science is that at least one well-designed, double-blind, placebo-controlled human trial exists. That does not mean the case is closed. It means we have a place to start.

Support Your Stress Response, Lower Cortisol and Feel Calmer, Clearer and More Like Yourself Again.

Try our new organic cortisol balance drops risk free

Verdant Cortisol Balance Drops - Calm Stress & Sleep Deeper

Shop Organic Cortisol Balance Drops

The Key Clinical Trial: 8-Week Randomized Study on Subclinical Hypothyroidism

The most cited piece of ashwagandha thyroid clinical evidence comes from a randomized, double-blind, placebo-controlled trial published on PubMed (PMID: 28829155), with data collected in 2017 and formally indexed in 2018. This is the trial that appears at the top of search results on Healthline, Medical News Today, and directly on PubMed itself — and for good reason. It is currently the primary human clinical study specifically examining ashwagandha thyroid function in a defined patient population.

Study Design at a Glance

| Parameter | Detail | |---|---| | Study type | Randomized, double-blind, placebo-controlled | | Population | Adults with subclinical hypothyroidism | | Total enrolled | 50 participants | | Completers | 46 (4 withdrew before visit 2) | | Intervention | Ashwagandha root extract 600 mg/day | | Duration | 8 weeks | | Primary outcomes | Serum TSH, T3, T4 levels |

Participants were randomized into two equal groups of 25. One group received 600 mg per day of standardized ashwagandha root extract — specifically the KSM-66 formulation — while the other received an identical-looking placebo capsule. Neither participants nor researchers knew which group received which treatment until the data lock.

The choice to study subclinical hypothyroidism was deliberate. People in this category have measurable thyroid insufficiency — their TSH is elevated, signaling the pituitary is pushing harder to stimulate a sluggish thyroid — but their peripheral hormone levels may still sit within the broad normal range. This makes them an ideal group for studying whether a natural compound can provide measurable normalization without crossing into pharmaceutical territory.

Importantly, all participants completed standard safety assessments throughout the trial. Adverse events were tracked systematically, and the trial followed ethical protocols consistent with clinical research standards.

What Happened to T3, T4, and TSH in the Study?

The results of this KSM-66 thyroid study are what generated significant attention in the integrative medicine community and are central to any honest discussion of ashwagandha T3 T4 effects.

Statistically Significant Improvements Across All Three Markers

After 8 weeks, the ashwagandha group showed statistically significant improvements in all three major thyroid markers compared to the placebo group:

• TSH: p < 0.001 (highly significant decrease)
• T3: p = 0.0031 (significant increase)
• T4: p = 0.0096 (significant increase)

In practical terms, as summarized by Healthline's analysis of the same trial:

• T3 increased by 41.5% in the ashwagandha group
• T4 increased by 19.6% in the ashwagandha group
• TSH decreased by 17.5% in the ashwagandha group

These are not trivial numbers. A 41.5% increase in T3 and a 17.5% decrease in TSH — if reproducible across larger trials — would represent clinically meaningful hormonal normalization. The authors concluded that ashwagandha may help normalize thyroid indices in subclinical hypothyroidism over an 8-week treatment period.

What Do These p-Values Actually Mean?

For readers unfamiliar with statistical terminology: a p-value represents the probability that the observed difference between groups could have occurred by chance. A p-value below 0.05 is the conventional threshold for "statistical significance." The p-values reported here — 0.001, 0.0031, 0.0096 — are all well below that threshold, meaning the probability that these results were random fluctuation is very low.

That said, p-values alone do not tell the whole story. With only 46 completers, this trial is small by pharmaceutical standards. Effect sizes and confidence intervals matter too, and the research community appropriately calls for replication before drawing firm clinical conclusions.

Adverse Events: Reassuringly Low in the Ashwagandha Group

One finding that often gets overlooked in discussions of this trial is the safety profile. Mild, temporary adverse effects were reported in just 4 out of 50 total enrolled participants — representing an 8% overall rate. The breakdown is striking:

• Ashwagandha group: 1 out of 25 participants (4%)
• Placebo group: 3 out of 25 participants (12%)

The adverse event rate was actually higher in the placebo group, which is consistent with a nocebo effect (negative symptoms triggered by expectation rather than the substance itself) and suggests the KSM-66 thyroid evidence from this trial includes a favorable short-term safety signal at the studied dose.

Animal Research and Preclinical Evidence

Beyond the human clinical trial, ashwagandha thyroid research includes a body of preclinical work that, while not directly translatable to human outcomes, helps scientists understand potential mechanisms.

A 2019 rat study, cited by Medical News Today in its coverage of this topic, suggested that ashwagandha may possess anti-hypothyroidism properties and improve thyroid function in animal models. The researchers observed changes in thyroid hormone parameters that aligned directionally with what was later seen in the human trial — increased T3 and T4 levels with reduced compensatory signals.

It is essential to place this finding in its proper context. Animal studies are preclinical evidence. Rats are not humans. Thyroid physiology shares broad similarities across mammals, but metabolic rates, hormone binding proteins, and autoimmune mechanisms differ substantially. A result in a rat study is hypothesis-generating, not hypothesis-confirming.

That said, the convergence of animal data and human clinical data pointing in the same direction is more encouraging than either strand of evidence alone.

Proposed Mechanisms

Researchers have proposed several mechanisms through which withania somnifera thyroid function might be influenced:

1. Adaptogenic modulation of the hypothalamic-pituitary-thyroid (HPT) axis: Ashwagandha's withanolides may influence the signaling cascade that regulates TSH secretion from the pituitary.

1. Antioxidant activity: Oxidative stress impairs thyroid hormone synthesis. Ashwagandha has demonstrated antioxidant properties in multiple studies, which could theoretically support thyroid cell function.

1. Cortisol reduction: High cortisol suppresses T3 conversion from T4. Since ashwagandha is well-documented to reduce cortisol levels, some researchers speculate this indirect pathway contributes to improved thyroid hormone profiles.

1. Direct thyroid stimulation: Some preclinical data suggest withanolides may directly stimulate thyroid cell activity, though this mechanism requires considerably more investigation.

None of these mechanisms have been confirmed as the primary driver of the observed human clinical results. Understanding mechanism is a research priority that remains open.

Safety Concerns: Thyrotoxicosis Case Reports

No discussion of ashwagandha and hypothyroidism is complete without addressing the safety signal that emerged in a 2022 case report and review published in PMC. This case report documented an association between ashwagandha supplementation and thyrotoxicosis — a state of excessive thyroid hormone levels that can cause heart palpitations, weight loss, anxiety, heat intolerance, and in severe cases, life-threatening cardiac complications.

What Is Thyrotoxicosis?

Thyrotoxicosis is the clinical syndrome resulting from elevated thyroid hormone levels in the bloodstream. It differs from hyperthyroidism in that it can also occur when thyroid tissue is destroyed (releasing stored hormones) or when exogenous thyroid hormone is ingested. Symptoms include:

• Rapid or irregular heartbeat
• Unexplained weight loss
• Tremors
• Excessive sweating
• Heat intolerance
• Anxiety and irritability
• Diarrhea

In the reported case, a patient developed thyrotoxicosis following ashwagandha supplementation. Upon discontinuation, hormone levels normalized — a pattern that implicated the supplement as the probable cause.

The Contradiction in the Literature

The 2022 PMC review explicitly notes that the existing literature on ashwagandha thyroid hormones is contradictory:

• Small, well-designed RCTs (like the PMID 28829155 trial) suggest benefit in hypothyroidism
• Case reports raise the possibility that ashwagandha can, in some individuals, cause excessive thyroid hormone elevation

This contradiction is not necessarily irreconcilable. Adaptogens are proposed to have bidirectional, normalizing effects — theoretically raising low hormones and lowering high ones. But this remains a theoretical framework, and the safety data is insufficient to confirm it. The more conservative interpretation is that ashwagandha's effect on thyroid hormones is real and potent enough to be clinically significant in both directions, which means it warrants respect and medical supervision.

Who Is Most at Risk?

Based on available evidence, the risk of thyrotoxicosis from ashwagandha appears to be rare but real. Risk factors that may increase vulnerability include:

• Pre-existing hyperthyroidism or borderline-elevated thyroid hormone levels
• Toxic nodular goiter or Graves' disease
• High-dose supplementation
• Concurrent use of other thyroid-stimulating herbs or supplements
• Iodine excess in combination with ashwagandha

Support Your Stress Response, Lower Cortisol and Feel Calmer, Clearer and More Like Yourself Again.

Try our new organic cortisol balance drops risk free

Verdant Cortisol Balance Drops - Calm Stress & Sleep Deeper

Shop Organic Cortisol Balance Drops

Ashwagandha and Hashimoto's Thyroiditis

Hashimoto's thyroiditis is the most common cause of hypothyroidism in developed countries. It is an autoimmune condition in which the immune system mistakenly attacks thyroid tissue, progressively impairing the gland's ability to produce hormones. Patients with Hashimoto's often experience the full spectrum of hypothyroid symptoms — fatigue, weight gain, depression, cold intolerance, brain fog — and many are drawn to integrative approaches to manage their condition.

The question of whether ashwagandha is safe and effective for Hashimoto's is one of the most common questions readers ask — and unfortunately, it is one the current research base cannot answer with confidence.

What We Know

The 2017/2018 human trial did not specifically study Hashimoto's patients. Participants were enrolled on the basis of subclinical hypothyroidism, without specifying autoimmune etiology. Some of those participants may have had Hashimoto's; the study did not stratify results by underlying cause.

The Immune-Modulation Concern

Ashwagandha is classified as an immunomodulator — meaning it can influence immune system activity. In theory, immune modulation could help or harm people with autoimmune thyroid disease depending on the direction and nature of the effect:

• If ashwagandha suppresses the autoimmune attack on thyroid tissue, it could be beneficial
• If it stimulates immune activation, it could worsen the autoimmune response

Current evidence does not clarify which direction predominates in Hashimoto's specifically. Some integrative practitioners use it cautiously in this population with apparent benefit, while others avoid it entirely. Without Hashimoto's-specific clinical trial data, neither position is evidence-based in a strong sense.

Practical Guidance for Hashimoto's Patients

If you have Hashimoto's and are considering ashwagandha:

1. Consult your endocrinologist or thyroid specialist first — not as a formality, but because your specific hormone levels, antibody titers, and medication status all matter
2. Get baseline thyroid labs before starting, so any changes can be detected
3. Monitor labs at 6–8 weeks if you proceed, consistent with the trial timeline
4. Report any new symptoms promptly — palpitations, increased anxiety, heat intolerance, or unexplained weight loss warrant immediate evaluation
5. Do not self-adjust thyroid medication based on how you feel while taking ashwagandha

Ashwagandha and Hyperthyroidism: A Crucial Warning

If the data on ashwagandha and hypothyroidism is cautiously promising, the picture for hyperthyroidism runs in the opposite direction entirely.

Hyperthyroidism — including Graves' disease, toxic multinodular goiter, and thyroiditis — involves excessive thyroid hormone production or release. Since ashwagandha thyroid function research suggests the herb may increase T3 and T4 while decreasing TSH, administering it to someone with already-elevated thyroid hormones could theoretically push levels further into dangerous territory.

The thyrotoxicosis case report discussed above reinforces this concern. A person with active or borderline hyperthyroidism who takes ashwagandha may experience:

• Worsening of existing symptoms
• Potentially triggering a thyroid storm in extreme cases (a rare but life-threatening emergency)
• Interference with medications used to treat hyperthyroidism (such as methimazole or propylthiouracil)

The current evidence strongly suggests that people with hyperthyroidism, Graves' disease, or any condition causing elevated thyroid hormone levels should avoid ashwagandha supplementation unless explicitly advised otherwise by a qualified healthcare provider.

This is not a theoretical precaution — it is grounded in the biological plausibility of the hormone-elevating effects documented in clinical research.

Dosage and Duration: What the Research Used

One of the most common practical questions about ashwagandha thyroid hormones research is: what dose was used, and how long does it take to work?

Dose Used in the Clinical Trial

The PMID 28829155 trial used 600 mg per day of standardized ashwagandha root extract (KSM-66). This is the specific formulation and dose for which the KSM-66 thyroid evidence exists. It was administered as divided doses, typically 300 mg twice daily, with meals.

KSM-66 is a specific branded extract standardized to contain a minimum percentage of withanolides — the bioactive compounds believed responsible for ashwagandha's effects. Not all ashwagandha products are equivalent. Differences in:

• Part of plant used (root vs. leaf vs. whole plant)
• Extraction method
• Withanolide concentration
• Standardization and quality control

...mean that a generic "ashwagandha 600 mg" capsule from an unspecified supplier is not necessarily the same as the KSM-66 extract studied in the trial. This matters significantly when interpreting whether supplement labels can promise thyroid benefits.

How Long Does It Take?

The clinical trial demonstrated statistically significant improvements in TSH, T3, and T4 over 8 weeks. This timeline is important for two reasons:

1. Patients should not expect overnight results — thyroid hormone changes are gradual processes tied to glandular function, not acute pharmacological responses
2. Labs should be checked at an appropriate interval — testing thyroid function at 2 weeks would likely miss the window of meaningful change

It is also unknown from the existing research whether benefits persist beyond 8 weeks, whether a maintenance dose is needed, or whether discontinuation leads to a return to baseline. These are significant gaps that future trials need to address.

Commonly Available Doses

Most commercial ashwagandha products on the market range from 300 mg to 600 mg per serving. The 600 mg/day dose used in the clinical trial falls within this range. Higher doses have not been specifically studied for thyroid outcomes and carry unknown risk profiles in this context.

Can Ashwagandha Interfere With Thyroid Medication or Lab Testing?

This is an area of genuine clinical concern that deserves direct attention.

Interaction With Levothyroxine (Synthroid)

Levothyroxine (T4 replacement) is among the most widely prescribed medications in the world. If ashwagandha genuinely increases endogenous T4 production, and a patient is simultaneously taking exogenous T4 via levothyroxine, the combination could push total T4 levels above the therapeutic range.

In practical terms, this could:

• Cause symptoms of thyroid hormone excess (palpitations, anxiety, weight loss)
• Require downward dose adjustment of levothyroxine
• Be detected on routine thyroid labs as a suppressed TSH with elevated free T4

None of this means the combination is necessarily dangerous, but it absolutely means it requires medical supervision and regular lab monitoring. Self-initiating ashwagandha while on levothyroxine without informing your prescriber is not advisable.

Interaction With Thyroid-Suppressing Medications

For patients on methimazole, carbimazole, or radioactive iodine therapy for hyperthyroidism, ashwagandha's potential to increase thyroid hormone production would directly counteract the therapeutic goal. This combination should be avoided unless specifically directed by an endocrinologist who has reviewed your complete hormone panel.

Effect on Lab Test Interpretation

There is currently no robust evidence that ashwagandha causes false positive or false negative results on standard thyroid lab panels (TSH, free T3, free T4, thyroid antibodies). However, if you are taking ashwagandha and your labs show unexpected changes, your physician needs to know about the supplement to correctly interpret the results.

Timing of Labs

Some practitioners recommend pausing supplements for 1–2 weeks before thyroid lab draws to get a true baseline reading of thyroid function without the herb's influence. This is a reasonable pragmatic approach, though it has not been formally studied.

What the Research Does Not Yet Tell Us

Honest science communication requires acknowledging what we do not know as clearly as what we do. Here is a frank assessment of the current gaps in ashwagandha thyroid research:

Sample Size

The primary human trial enrolled just 50 people. In pharmaceutical research, pivotal trials typically enroll hundreds to thousands of participants. Small samples increase the risk of results driven by chance, and reduce the ability to detect rare adverse events or identify which subgroups benefit most.

Single Trial Problem

To date, there is essentially one well-designed human clinical trial examining ashwagandha thyroid clinical outcomes. Science requires replication. One study — even a well-conducted one — is a starting point, not a conclusion.

Limited to Subclinical Hypothyroidism

The trial studied a specific population: adults with subclinical hypothyroidism. Results may not translate to:

• People with overt hypothyroidism (requiring medication)
• People with normal thyroid function seeking "optimization"
• People with Hashimoto's thyroiditis specifically
• Children or adolescents
• Pregnant or breastfeeding individuals
• Elderly patients
• People with comorbid thyroid conditions

No Long-Term Safety Data

The 8-week trial provides only short-term safety data. Long-term effects of daily ashwagandha on thyroid function — whether taken for months or years — are unknown.

No 2024–2026 Clinical Trials Identified

Based on the available research landscape, no new primary clinical trials or peer-reviewed studies specifically examining ashwagandha and thyroid function in humans were published between 2024 and 2026 at the time of this writing. The field has not materially advanced beyond the 2017/2018 trial in terms of human clinical evidence. This is itself a significant observation — five-plus years without a follow-up replication trial suggests the research gap remains wide open.

Mechanism Not Confirmed

As outlined earlier, the mechanism by which ashwagandha influences thyroid hormones is not definitively established in humans. Without understanding mechanism, predicting who will benefit, who will be harmed, and at what dose remains difficult.

Support Your Stress Response, Lower Cortisol and Feel Calmer, Clearer and More Like Yourself Again.

Try our new organic cortisol balance drops risk free

Verdant Cortisol Balance Drops - Calm Stress & Sleep Deeper

Shop Organic Cortisol Balance Drops

Frequently Asked Questions

Can ashwagandha improve an underactive thyroid?

Based on the best available evidence — the 2017/2018 randomized controlled trial (PMID: 28829155) — ashwagandha root extract at 600 mg/day demonstrated statistically significant improvements in TSH, T3, and T4 over 8 weeks in adults with subclinical hypothyroidism. This is encouraging preliminary evidence. However, it is not a substitute for prescribed thyroid medication in people with overt or clinically significant hypothyroidism, and should be discussed with a healthcare provider before use.

Does ashwagandha raise T3 and T4 levels?

Yes, the clinical trial data on ashwagandha T3 T4 shows that in the ashwagandha group, T3 increased by approximately 41.5% and T4 increased by approximately 19.6% over 8 weeks, compared to placebo. These changes were statistically significant (T3: p = 0.0031; T4: p = 0.0096).

Can ashwagandha lower TSH?

Yes. In the same trial, TSH decreased by approximately 17.5% in the ashwagandha group, with a p-value of less than 0.001 — the most statistically significant result in the study. Since elevated TSH in subclinical hypothyroidism indicates the pituitary is compensating for insufficient thyroid output, a TSH reduction in this context is a marker of improvement.

Is ashwagandha safe for Hashimoto's disease?

This question cannot be answered definitively with current evidence. The clinical trial did not specifically study Hashimoto's patients, and ashwagandha's immunomodulatory properties create theoretical uncertainty in autoimmune thyroid disease. Medical supervision, baseline labs, and careful monitoring are essential if considering ashwagandha with Hashimoto's.

Can ashwagandha worsen hyperthyroidism?

Yes, this is a genuine concern. Given that ashwagandha appears to increase thyroid hormone levels, people with hyperthyroidism or Graves' disease should avoid it unless explicitly cleared by a physician. A 2022 case report documented thyrotoxicosis associated with ashwagandha use.

What dose of ashwagandha was used in thyroid studies?

The human clinical trial used 600 mg per day of KSM-66 ashwagandha root extract. This is the dose for which clinical evidence currently exists in the context of thyroid function.

How long does it take to affect thyroid labs?

The clinical trial demonstrated significant changes over 8 weeks. This is the only evidence-based timeframe available. Shorter durations may be insufficient, and longer-term effects are not yet studied.

Can ashwagandha interfere with thyroid medication or lab testing?

Ashwagandha's potential to increase T3 and T4 could interact with both levothyroxine and thyroid-suppressing medications. It is essential to inform your prescriber if you are taking or plan to take ashwagandha while on thyroid medication. It does not appear to directly interfere with lab assays, but supplement use should always be disclosed when interpreting thyroid labs.

Are there reports of thyrotoxicosis or thyroiditis from ashwagandha?

Yes. A 2022 PMC case report documented ashwagandha-associated thyrotoxicosis that resolved upon discontinuation. This represents rare but real safety data that anyone considering ashwagandha for thyroid health should be aware of.

Should people with autoimmune thyroid disease avoid it?

There is currently insufficient evidence to give a definitive recommendation. The theoretical concern about immune modulation in autoimmune thyroid conditions warrants caution. Anyone with autoimmune thyroid disease — whether Hashimoto's or Graves' — should consult a qualified healthcare provider before taking ashwagandha.

The Bottom Line

The research on ashwagandha for thyroid function occupies an interesting and genuinely important space in integrative medicine: it is not the typical supplement story built on folklore and marketing copy alone. There is real, peer-reviewed, double-blind clinical evidence — specifically the KSM-66 thyroid study published as PMID 28829155 — showing statistically significant improvements in TSH, T3, and T4 in adults with subclinical hypothyroidism over 8 weeks of supplementation at 600 mg/day.

That evidence matters. A 41.5% increase in T3, a 19.6% increase in T4, and a 17.5% decrease in TSH are not trivial changes in a randomized controlled trial. The KSM-66 thyroid evidence represents the strongest human clinical signal in the withania somnifera thyroid research landscape to date.

At the same time, intellectual honesty demands acknowledging what the evidence cannot support:

• The trial was small (50 participants)
• It has not been replicated in independent large-scale trials
• It studied subclinical hypothyroidism specifically, not other thyroid conditions
• Long-term safety data does not exist
• Case reports of thyrotoxicosis confirm that real risk exists in some individuals

The fact that ashwagandha thyroid hormones can move measurably in clinical studies is precisely why this is not a supplement to take casually. Thyroid hormones regulate nearly every organ system in the body. Meaningful changes to thyroid hormone levels — in either direction — have real physiological consequences.

Who might benefit most from discussing this with their doctor: Adults with confirmed subclinical hypothyroidism who are in a watchful waiting phase, are seeking non-pharmaceutical options, and can commit to baseline and follow-up lab monitoring.

Who should exercise significant caution or avoid it: Anyone with hyperthyroidism, Graves' disease, active thyrotoxicosis, or Hashimoto's thyroiditis, and anyone currently taking levothyroxine, methimazole, or other thyroid medications without medical supervision.

The bottom line is this: ashwagandha is one of the few herbal supplements with clinically meaningful human trial data specifically examining thyroid hormone outcomes. That earns it serious consideration. But serious consideration means working with your healthcare provider, monitoring your labs, and not assuming that "natural" equals "safe at any dose for any thyroid condition."

The science is promising. It is also incomplete. Both of those things are true at the same time.

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any supplement, particularly if you have a diagnosed thyroid condition or are taking thyroid medications.

Sources: PubMed PMID 28829155 (2018 randomized controlled trial); Healthline analysis of ashwagandha thyroid research; Medical News Today review of ashwagandha and thyroid; 2022 PMC case report on ashwagandha-associated thyrotoxicosis; 2019 preclinical rat study cited in Medical News Today.